Trial Profile
An open label multicentre trial to evaluate safety and efficacy of plasminogen concentrate in patients with Ligneous Conjunctivitis (LC)
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 20 Jan 2016
Price :
$35
*
At a glance
- Drugs Plasminogen (Primary)
- Indications Type I plasminogen deficiency
- Focus Therapeutic Use
- 20 Jan 2016 New trial record
- 08 Dec 2015 Results (n=11), presented at the 57th Annual Meeting and Exposition of the American Society of Hematology.